Asia-Pacific Pharmaceuticals: intends to establish a wholly-owned subsidiary with its own funds of 50 million yuan.

Asia Pacific Pharmaceutical announced that the company plans to establish a wholly-owned subsidiary, Zhejiang Yatai Lizhong Investment Holding Co., Ltd., with its own funds of 50 million yuan. This external investment does not constitute a related party transaction, nor does it constitute a major asset restructuring as defined in the Regulations on the Management of Major Asset Restructuring of Listed Companies.